These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8954280

  • 1. [New drug therapies].
    Olié JP, Baylé FJ.
    Encephale; 1996 Oct; 22 Spec No 3():63-71; discussion 76. PubMed ID: 8954280
    [No Abstract] [Full Text] [Related]

  • 2. The treatment of negative symptoms: pharmacological and methodological issues.
    Carpenter WT.
    Br J Psychiatry Suppl; 1996 May; (29):17-22. PubMed ID: 8733819
    [No Abstract] [Full Text] [Related]

  • 3. Management of treatment refractory schizophrenia.
    Morrison DP.
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract] [Full Text] [Related]

  • 4. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract] [Full Text] [Related]

  • 5. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C, Bret P, Bret MC, Queuille E.
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [Abstract] [Full Text] [Related]

  • 6. Do anticonvulsants hinder clozapine treatment?
    Wilson WH.
    Biol Psychiatry; 1995 Jan 15; 37(2):132-3. PubMed ID: 7718678
    [No Abstract] [Full Text] [Related]

  • 7. [Clozapine and treatment of negative symptoms].
    Lançon C, Farisse J, Llorca PM.
    Encephale; 1997 Sep 15; 23 Spec No 4():7-11. PubMed ID: 9417403
    [Abstract] [Full Text] [Related]

  • 8. [Weight gain and clozapine].
    Jalenques I, Tauveron I, Albuisson E, Audy V.
    Encephale; 1996 Oct 15; 22 Spec No 3():77-9. PubMed ID: 8954282
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
    Stengler-Wenzke K.
    Psychiatr Prax; 1999 May 15; 26(3):145-6. PubMed ID: 10412713
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of clozapine on neuroimaging findings in schizophrenia.
    Ertugrul A, Uluğ B.
    Psychiatr Danub; 2007 Dec 15; 19(4):367-9. PubMed ID: 18000491
    [Abstract] [Full Text] [Related]

  • 18. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J, Ault K, Powchik P.
    Biol Psychiatry; 1997 Sep 15; 42(6):522-3. PubMed ID: 9285089
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.